RecruitingNot ApplicableNCT07276646

Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy

Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy: A Randomized Clinical Trial.


Sponsor

Zagazig University

Enrollment

80 participants

Start Date

Dec 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction


Eligibility

Min Age: 21 YearsMax Age: 64 Years

Inclusion Criteria7

  • patient acceptance
  • Age: 21-64 years old.
  • Sex: both sexes.
  • Physical status: ASA I \& II.
  • Body mass index (BMI): 18.5 - 30 kg/m2.
  • Type of operations: elective laparoscopic cholecystectomy.
  • Duration of surgery not more than 2 hours.

Exclusion Criteria4

  • Known hypersensitivity to lidocaine or bupivacaine.
  • Patients with respiratory insufficiency.
  • Coagulation disorders or taking drugs affect surgical hemostasis.
  • \. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERetrosuperior costotransverse ligament block group

The patient will receive retrosuperior costotransverse ligament block

PROCEDUREErector spinae block group

The patient will receive erector spinae block.


Locations(1)

Faculty of human medicine, Zagazig university, Zagazig

Zagazig, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07276646


Related Trials